These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
140 related items for PubMed ID: 31681999
1. Co-occurrence of BCR-ABL1-positive chronic myeloid leukaemia and CALR-mutated essential thrombocythaemia. da Costa VEF, de Oliveira RD, Traina F, Chahud F, Palma LC, de Figueiredo-Pontes LL. Br J Haematol; 2020 Feb; 188(3):e21-e23. PubMed ID: 31681999 [No Abstract] [Full Text] [Related]
7. CALR-mutated primary myelofibrosis evolving to chronic myeloid leukemia with both CALR mutation and BCR-ABL1 fusion gene. Diamond JM, de Almeida AM, Belo HJ, da Costa MP, Cabeçadas JM, Abecasis MM. Ann Hematol; 2016 Dec; 95(12):2101-2104. PubMed ID: 27699446 [No Abstract] [Full Text] [Related]
11. CALR, JAK2 and MPL mutation status in Argentinean patients with BCR-ABL1- negative myeloproliferative neoplasms. Ojeda MJ, Bragós IM, Calvo KL, Williams GM, Carbonell MM, Pratti AF. Hematology; 2018 May 12; 23(4):208-211. PubMed ID: 28990497 [Abstract] [Full Text] [Related]
12. The Polymorphisms in LNK Gene Correlated to the Clinical Type of Myeloproliferative Neoplasms. Chen Y, Fang F, Hu Y, Liu Q, Bu D, Tan M, Wu L, Zhu P. PLoS One; 2016 May 12; 11(4):e0154183. PubMed ID: 27111338 [Abstract] [Full Text] [Related]
13. Monocyte-derived dendritic cells from chronic myeloid leukaemia have abnormal maturation and cytoskeletal function that is associated with defective localisation and signalling by normal ABL1 protein. Brown S, Hutchinson CV, Aspinall-O'Dea M, Whetton AD, Johnson SM, Rees-Unwin K, Burthem J. Eur J Haematol; 2014 Aug 12; 93(2):96-102. PubMed ID: 24617663 [Abstract] [Full Text] [Related]
14. Secondary chronic myeloid leukemia in a patient with CALR and ASXL1-mutated primary myelofibrosis. Sobieralski P, Bieniaszewska M, Leszczyńska A, Żuk M, Wasąg B, Zaucha JM. Int J Hematol; 2022 Sep 12; 116(3):442-445. PubMed ID: 35429330 [Abstract] [Full Text] [Related]
15. The Role of Mutated Calreticulin in the Pathogenesis of BCR-ABL1-Negative Myeloproliferative Neoplasms. Vadeikienė R, Jakštys B, Laukaitienė D, Šatkauskas S, Juozaitytė E, Ugenskienė R. Int J Mol Sci; 2024 Sep 12; 25(18):. PubMed ID: 39337361 [Abstract] [Full Text] [Related]
16. Elevated platelet count features the variant type of BCR/ABL junction in chronic myelogenous leukaemia. Yamagata T, Mitani K, Kanda Y, Yazaki Y, Hirai H. Br J Haematol; 1996 Aug 12; 94(2):370-2. PubMed ID: 8759898 [Abstract] [Full Text] [Related]
17. Clinical and hematological relevance of JAK2 V617F and CALR mutations in BCR-ABL-negative ET patients. Limsuwanachot N, Rerkamnuaychoke B, Chuncharunee S, Pauwilai T, Singdong R, Rujirachaivej P, Chareonsirisuthigul T, Siriboonpiputtana T. Hematology; 2017 Dec 12; 22(10):599-606. PubMed ID: 28406068 [Abstract] [Full Text] [Related]